Author: Gina Lizet
NTI-specific substitution laws: which states have special rules
Twenty-seven states have special rules blocking or restricting generic substitution for Narrow Therapeutic Index (NTI) drugs like warfarin and levothyroxine. These state laws override FDA guidelines and create a patchwork of requirements - from mandatory consent to outright bans.
Read more
Hashimoto’s Thyroiditis: Understanding Autoimmune Hypothyroidism and TSH Monitoring
Hashimoto’s thyroiditis is the leading cause of hypothyroidism in the U.S., affecting 4% of adults. TSH monitoring is the cornerstone of treatment, guiding levothyroxine dosing to restore normal thyroid function and prevent complications.
Read more
How Paragraph IV Patent Challenges Speed Up Generic Drug Entry
Paragraph IV under the Hatch-Waxman Act lets generic drug makers challenge brand patents to speed up affordable drug access. It’s how most generic drugs enter the market-and why prices drop so sharply.
Read more
How to Prepare for Pediatric Procedures with Pre-Op Medications
Learn how to safely prepare your child for surgery using pre-op medications, fasting rules, and anxiety-reducing strategies backed by pediatric anesthesia guidelines. Reduce fear, prevent complications, and ensure a smoother experience.
Read more
Common Translation Issues on Prescription Labels and How to Get Help
Millions of Americans struggle with mistranslated prescription labels, leading to dangerous medication errors. Learn why translation fails, how it harms patients, and what you can do to get accurate instructions.
Read more
How to Communicate with Your Pharmacy During Generic Drug Transitions
When your medication switches to a generic, communication with your pharmacy is key. Learn how to prepare, what to watch for, and how to speak up if something feels off.
Read more
Shared Decision-Making Scripts for Side Effect Trade-Offs in Medication Choices
Shared decision-making scripts help patients and doctors weigh medication side effects together, leading to better adherence, fewer regrets, and more personalized care. Learn how clear communication and real numbers make a difference.
Read more
Manufacturing Changes and Generic Approval: What Triggers FDA Re-Evaluation
Manufacturing changes in generic drugs can trigger full FDA re-evaluation. Learn what modifications require prior approval, how long reviews take, and how new programs are speeding up the process.
Read more
SGLT2 Inhibitors and Diabetic Ketoacidosis Risk: Symptoms, Causes, and Prevention
Learn how SGLT2 inhibitors for type 2 diabetes can cause diabetic ketoacidosis even with normal blood sugar. Understand symptoms, risk factors, and how to prevent this serious complication. Includes latest guidelines and real-world data on managing this rare but dangerous side effect.
Read more
De facto combinations: Why taking separate generics instead of FDCs is common - and risky
Many patients take separate generic drugs instead of fixed-dose combinations (FDCs) for cost or dosing reasons. But this practice, called a de facto combination, carries hidden risks like lower adherence and untested drug interactions. Learn when it's safe - and when it's not.
Read more
Medical Weight Management: Clinics, Medications, and Monitoring
Medical weight management combines clinics, FDA-approved medications like Wegovy and Zepbound, and ongoing monitoring to treat obesity as a chronic disease. Learn how it works, who qualifies, and why it’s more effective than diet programs.
Read more
Gestational Diabetes: How to Manage Blood Sugar During Pregnancy
Learn how to manage blood sugar during pregnancy with gestational diabetes through diet, exercise, monitoring, and when medication is needed. Reduce risks to you and your baby with proven, practical strategies.
Read more